Enlie Pharmaceutical JSC

Enlie Pharmaceutical JSC EBITDA per Share

The EBITDA per Share of Enlie Pharmaceutical JSC (BCP.VN) as of Nov 5, 2026 is 705.48 VND. In the previous year, EBITDA per Share was -538.10 VND — a change of -231.10% (higher).

EBITDA per Share

705.48VND

YoY

-231.10%

Last updated:

EBITDA per Share of Enlie Pharmaceutical JSC is 2024 705.48 VND. EBITDA per Share of Enlie Pharmaceutical JSC was 2023 -538.10 VND. It decreases by -231.10% higher compared to the previous year.

The Enlie Pharmaceutical JSC EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2017
2,201.00 VND
Jan 1, 2018
2,929.00 VND
Jan 1, 2019
-501.00 VND
Jan 1, 2020
-1,955.83 VND
Jan 1, 2021
-697.83 VND
Jan 1, 2022
393.04 VND
Jan 1, 2023
-538.10 VND
Jan 1, 2024
705.48 VND
The Enlie Pharmaceutical JSC EBITDA per Share history
YEAREBITDA per ShareYoY
705.48VND-231.10%
-538.10VND-236.91%
393.04VND-156.32%
-697.83VND-64.32%
-1,955.83VND+290.39%
-501.00VND-117.10%
2,929.00VND+33.08%
2,201.00VND+30.86%
1,682.00VND+33.25%
1,262.25VND-54.11%
2,750.75VND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Enlie Pharmaceutical JSC Stock analysis

What does Enlie Pharmaceutical JSC do? Enlie Pharmaceutical JSC generates revenue primarily through the manufacture and commerce of pharmaceutical preparations, medical equipment, and health supplements. The company leverages its core expertise in these healthcare categories to serve the market, establishing its primary income streams around the production and sale of these essential health products. In addition to its pharmaceutical operations, the firm has diversified its business model by expanding into the real estate industry. This segment involves the development of various commercial and residential infrastructures which are then made available for lease, providing an additional layer of financial activity beyond its core healthcare focus. Enlie Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enlie Pharmaceutical JSC stock

EBITDA per Share of Enlie Pharmaceutical JSC is 705.48 VND in 2024.

EBITDA per Share of Enlie Pharmaceutical JSC changed from -538.10 VND to 705.48 VND, representing a -231.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Enlie Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Enlie Pharmaceutical JSC

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Enlie Pharmaceutical JSC